Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1001-1025 of 2409. (97 Page(s) Totally) << < 36 37 38 39 40 41 42 43 44 45 > >> View [10|25|50] records per page

Date	Title	Relation
2016-11	Advances in molecular genetics of early-stage urothelial carcinoma	Translational Cancer Research. 2016 Nov;5(Suppl. 6):S1126-S1130.
2016-11	Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer	Journal of Gastroenterology and Hepatology. 2016 Nov;31(Suppl. 3):245.
2016-11	IL-1b mediates anti-progression activities in renal cell carcinoma by inducing MCP-1	Annals of Oncology. 2016 Nov;27(Suppl. 8):Meeting Abstract 35P.
2016-10-26	High expression of 17beta-hydroxysteroid dehydrogenase type 2 is associated with a better prognosis in urothelial carcinoma of the urinary tract	Journal of Cancer. 2016 Oct 26;7(15):2221-2230.
2016-10-25	A comprehensive analysis on the association between tobacco-free Betel Quid and risk of Head and Neck Cancer in Taiwanese men	PLoS ONE. 2016 Oct 25;11(10):Article number e0164937.
2016-10-25	Downregulation of RNF128 predicts progression and poor prognosis in patients with Urothelial Carcinoma of the upper tract and urinary bladder	Journal of Cancer. 2016 Oct 25;7(15):2187-2196.
2016-10-21	MCM10 overexpression implicates adverse prognosis in urothelial carcinoma	Oncotarget. 2016 Oct 21;7(47):77777-77792.
2016-10-01	The prognostic impact of overall treatment time on disease outcomes of uterine cervical cancer patients: A nationwide cohort study of Taiwan	International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):E301.
2016-10-01	The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan	International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):S15-S16.
2016-10	The ubiquitin ligase itch and ubiquitination regulate BFRF1-mediated nuclear envelope modification for Epstein-Barr Virus maturation	Journal of Virology. 2016 Oct;90(20):8994-9007.
2016-10	Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor	Cancer Research and Treatment. 2016 Oct;48(4):1155-1166.
2016-10	BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia	Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
2016-10	Klf10 deficiency in mice exacerbates pulmonary inflammation by increasing expression of the proinflammatory molecule NPRA	International Journal of Biochemistry and Cell Biology. 2016 Oct;79:231-238.
2016-10	Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway	Cancer Science. 2016 Oct;107(10):1390-1398.
2016-10	Predictors of survival in esophageal squamous cell carcinoma with pathologic major response after neoadjuvant chemoradiation therapy and surgery: The impact of chemotherapy protocols	BioMed Research International. 2016 Oct;2016:Article number 6423297.
2016-10	Effects of nanoliposomal irinotecan (nal-IRI;MM-398) +/- 5-Fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1: A phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-b	Oncology Research and Treatment. 2016 Oct;39(Suppl. 3):259.
2016-10	Quality-adjusted time without symptoms or toxicity (Q-TWIST) of nanoliposomal irinotecan (nal-IRI;MM-398) plus 5-fluorouracil and leucavorin (5-FU/LV) vs 5-FU/LV alone in patients with metastatic pancreatic adenocarcinoma (mPAC) previously treated with ge	Oncology Research and Treatment. 2016 Oct;39(Suppl. 3):260.
2016-10	Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Annals of Oncology. 2016 Oct;27(Suppl. 6):Meeting Abstract 622PD.
2016-10	Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based ther	Annals of Oncology. 2016 Oct;27(Suppl. 6):Meeting Abstract 693P.
2016-10	CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma	Annals of Oncology. 2016 Oct;27(Suppl. 6):Meeting Abstract 933P.
2016-10	The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study	Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
2016-09-15	The DNA damage transducer RNF8 facilitates cancer chemoresistance and progression through twist activation	Molecular Cell. 2016 Sep 15;63(6):1021-1033.
2016-09-12	The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals	Nature Genetics. 2016 Sep 12;48(10):1171-1184.
2016-09	A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination	Oncogene. 2016 Sep;35(35):4653-4662.
2016-09	Trend in and correlates of undergoing radiotherapy in Taiwanese cancer patients' last month of life	Journal of Pain and Symptom Management. 2016 Sep;52(3):395-403.

Showing items 1001-1025 of 2409. (97 Page(s) Totally) << < 36 37 38 39 40 41 42 43 44 45 > >> View [10|25|50] records per page